cDNA copies of the M and N genes of equine arteritis virus (EAV) isolates were synthesized by reverse transcription followed by polymerase chain reaction amplification. The cDNA was subjected to a cycle sequencing strategy using Taq polymerase, and the nucleotide and derived amino acid sequences of 10 virus isolates were compared. The M and N genes of all isolates had the same initiation and termination sites as the prototype
The Arterivirus family are a group of small, enveloped, positive-stranded RNA viruses and include equine arteritis virus (EAV), Lelystad virus (LV), lactate dehydrogenase-elevating virus (LDV) and simian haemorrhagic fever virus. EAV, the prototype Arterivirus, is the aetiological agent of equine viral arteritis, a debilitating respiratory disease which, at its most severe, is abortigenic. EAV genome expression and replication strategy resembles that of corona-and toroviruses (den Boon et al., 1991) with multiple subgenomic (sg) RNAs produced in EAV-infected cells (van Berlo et al., 1982) ; however, virion size and morphology are comparable to those of togaviruses. The EAV nucleocapsid consists of an infectious, polyadenylated, 12.7 kb ssRNA bound to a 12K core protein (N). The envelope contains three structural proteins: M a 16K unglycosylated protein, GL a 28K to 42K glycosylated protein and G s a 21K glycosylated protein (de Vries et al., 1992) .
Virus transmission can occur by both the respiratory (McCollum et al., 1961) and venereal routes and approximately 30% of stallions infected with EAV subsequently become long-term shedders of virus in their semen (Timoney et al., 1986) . Serological studies have provided evidence of global distribution of EAV infection (Huntingdon et al., 1990; Kaaden et al., 1989; McCollum & Bryans, 1973; McKenzie, 1988; Moraillon & Moraillon, 1978) .
Cross-neutralization studies have failed to demon-
The sequence data presented in this paper have been submitted to the EMBL database and assigned accession numbers X78492 to X78501. strate antigenic variation between EAV isolates (Fukunaga & McCollum, 1977; Golnik et al., 1986) . However RNase T1 oligonucleotide fingerprinting has demonstrated that genomic variation exists between EAV isolates (Murphy et al., 1988 (Murphy et al., , 1992 . As part of a molecular epidemiological study of viral arteritis we have compared the nucleotide and amino acid sequences of the M and N genes of 10 EAV isolates with the prototype Bucyrus strain sequences (den Boon et al., 1991) .
The origins of the EAV isolates analysed and their full designations are shown in Table 1 . The Bucyrus (BUC), Kentucky 84 (KEN), Swiss (BIB) and Austrian (VEN) isolates are derived from separate respiratory disease cases, the Polish (WRC, 185) viruses from fetal tissue and the two Norwegian isolates (N1, N2) are semen isolates from seropositive stallions. Arvac (ARV) is a tissue culture-attenuated vaccine virus derived from the original Bucyrus isolate. PF, isolated from the pleural fluid of a horse that died as a result of experimental virus infection (Doll et al., 1957) , and KS, a laboratorypassaged virus, are also Bucyrus derivatives.
Rabbit kidney cells (RK-13) in 500 ml tissue culture flasks were infected with EAV and the supernatant was harvested when 80% c.p.e, became evident. Tissue culture supernatant was clarified by centrifugation for 10 min at 4000 g at 4 °C, and virus stocks were stored in 1 ml aliquots at -70 °C. Virus RNA extraction, reverse transcription and genome amplification were performed as previously described (Chirnside & Spaan, 1990) . Oligonucleotide 64 (5' TGGTTCCTGGGTGGC 3') was used to prime reverse transcription (RT) and oligonucleotides 06/90 and 04/91 (5'GGCAGCTGAG- GTATGGGA 3' and 5' TTGGATCCTGGGTGGCT-AATAACTACTT 3', respectively), located at nucleotides (nt) 11890 to 11909 and 12680 to 12706 were used to prime specific PCR amplification of an 817bp fragment at the 3' end of the EAV genome containing the M and N genes. A portion (5 gl) of the amplification mix was analysed by agarose gel electrophoresis to confirm that a band of the expected size had been amplified and the remaining product was purified from unincorporated primer using Magic Minipreps (Promega). The resulting cDNA was used directly in a cycle sequencing procedure (Gibco-BRL) with 3~P-labelled primers. The nucleotide sequence was determined repetitively on both cDNA strands using EAV-specific primers, and the prototype Bucyrus strain was sequenced as an internal control of the RT/PCR and cycle sequencing strategy. The nucleotide and derived amino acid sequences were analysed using DNASIS software (Hitachi/Pharmacia).
The region sequenced corresponds to nt 11908 to 12679, within the 817 bp fragment (nt 11890 to 12706) of the Bucyrus strain. The complete M and N gene sequences ( Fig. 1 ) and deduced amino acid sequences (not shown) of the EAV isolates were aligned and compared to the published Bucyrus sequence. Oligonucleotide primer 06/90 includes the first six nucleotides of the M open reading frame (ORF) and this ORF was therefore assumed to start at the primer-encoded ATG codon at position 11902 and terminated with the TGA codon at position 12390. The N ORF is initiated at the ATG at position 12314 and terminated at position 12646 with the TAA codon. The EAV isolates exhibited high nucleotide sequence conservation, evident from the fact that no insertions were required to align the nucleotide sequences.
Analysis of the nucleotide and deduced amino acid sequences of the M and N genes (Table 2) indicates that the M gene nucleotide sequence identity was ~> 97 % between BUC, PF, KS, KEN, 185 and ARV, falling to 94 to 96 % for WRC, N1 and N2, and ~< 93 % for BIB and VEN. The N gene nucleotide sequences remained >/97% identical between all the isolates with the exception of BIB (94 to 95 %). These results indicate that BUC and its derivatives (PF, KS and ARV), KEN and 185 are more closely related to each other than they are to the remaining isolates, and that BIB and VEN are the isolates most distantly related to the BUC prototype. However BIB and VEN share only 93 % M gene identity indicating that they are not closely related to one another. The semen isolates N1 and N2 exhibited close homology to the Bucyrus-type isolates.
The CLUSTAL program was used to analyse comparisons between nucleotide sequences in order to generate phylogenetic trees illustrating relationships between EAV M and N proteins (Fig. 2) . CLUSTAL uses the unweighted pair group maximum averages (UPGMA) method of phylogenetic inference (Higgins & Sharp, 1988; Sharp et al., 1991) to derive a preliminary phylogeny which guides the alignment of sequences. The finished phylogeny is produced by applying the neighbour-joining method of Saitou & Nei (1987) to the distance and alignment data.
The phylogenetic tree based on M gene sequence analysis indicates that three distinct EAV variants exist. The BIB and VEN isolates form branches distinct from the other EAV isolates. Comparison of nucleotide sequence homology and phylogenetic trees (Fig. 2) between the N genes of BIB and VEN indicates that the N gene of VEN is a significantly closer relative to the BUC prototype N gene than the M gene sequence homology indicates. The VEN sequence contains 36 nucleotide substitutions relative to the BUC sequence between nt 11908 and 12240, and only two substitutions between nt 12240 and 12679. The shift in nucleotide homology suggests that a recombination event may have occurred between two TCAAC motifs (nt 12185 and 12253) directly 5' to the N gene. Multiple TCAAC motifs are located upstream of ORFs on the EAV genome (de Vries et al., 1990; den Boon et al., 1991) and are believed to be involved during replication as leader-body junction sites in the genesis of viral sgRNAs. Putative leader-body junction sites have also been identified on the genomes of LV (Meulenberg et al., 1993) and LDV (Kuo et al., 1992) . Arterivirus replication is similar to that of coronaviruses (de Vries et al., 1990; den Boon et al., 1991) during which RNA recombination, unusual amongst RNA viruses, has been reported to occur (Banner et al., 1990; Banner & Lai, 1991; Keck et al., 1988; Lai et al., 1985; Makino et al., 1986; Wang et al., 1993) .
The EAV TCAAC motif located at nt 12253 is believed to be the site of RNA leader-body fusion for sgRNA 7 during EAV replication (de Vries et al., 1990) , in preference to the 5' motif at nt 12185. The downstream motif remained conserved between EAV isolates. However the upstream motif was corrupted in the BIB and N1 isolates; this is an additional indication that the TCAAC site at nt 12253 is the leader-body junction site, as the functionally active motifs are expected to be conserved between strains as essential sites in the RNA leader-body fusion process.
Genomic variation between EAV isolates has previously been indicated by RNase T1 fingerprint analysis (Murphy et al., 1988 (Murphy et al., , 1992 . In addition to these earlier studies, the observation of a varying clinical picture between infectious outbreaks (Clayton, 1987; Doll et al., 1957; McCollum & Bryans, 1973) , and persistent semen shedding of virus amongst some seropositive stallions (Neu et al., 1988; Timoney et al., 1986) , have indicated that variation may exist between viruses. Direct nucleotide sequence comparisons show substitutions in the M and N genes and allow EAV strains to be distinguished. Nucleotide sequence information is important in molecular epidemiological studies determining the origin and spread of viral arteritis, monitoring the extent and efficacy of vaccination schemes, and for improving the detection of virus variants.
Antigenic differences have not been identified amongst EAV isolates in cross-neutralization tests (Burki, 1965; Golnik et al., 1986) or in cross-protection experiments in horses (McCollum, 1969) . The deduced amino acid sequences indicate several non-conserved amino acid substitutions in the N and M proteins, the functional significance of which remains unknown. These proteins are integral to preserving the structure of the EAV virion (de Vries et al., 1992) and N may be under strict functional constraints. Additionally, as an internal protein N is unlikely to be subjected to major antibody selection pressure resulting in antigenic change.
Studies of nucleotide sequence variation amongst members of the Arterivirus family have been confined to alignments of RNA-dependent RNA polymerase sequences (Godeny et al., 1993) and to analysis of the 3' end of the genomes of LDV-P and LDV-C (Kuo et al., 1992) . The proposed LDV N gene (VP-1) exhibits only 86% identity between the two LDV isolates. However, similar to EAV, the deduced N protein has a conserved amino acid sequence. Nucleic acid sequence substitutions in VP-2 of LDV account for the viral integral membrane protein variability, however it is in the LDV VP-3 gene that the greatest variation in both nucleotide and amino acid sequences occurs between LDV-P and LDV-C. The variability of the EAV M and N genes and proteins appears to follow a pattern similar to those of LDV isolates and important antigenic differences are most likely to be found in the EAV large envelope glycoprotein G~,, which corresponds to LDV VP-3. An amino acid sequence identity of 23 % and 20 % respectively has been found between the EAV and LV M and N proteins (Meulenberg et al., 1993) . The LV proteins are most similar to those of LDV with 53 % and 41% identity for the M and N proteins, respectively.
All EAV isolates possessed identical sequences from nt 12647 to 12679 within the 3' end non-coding region. The extreme 3' end of the EAV genome from nt 12680 was primer-derived in all except the Bucyrus sequence. This region of the EAV genome is likely to play an important role in virus replication and assembly and, in common with LDV isolates (Kuo et al., 1992) and many other positive-stranded RNA viruses, may remain identical in EAV isolates.
This study is the first to report EAV strain variation at Table 1 for EAV isolate abbreviations. BUC  97  96  99  96  96  99  98  99  98  100  PF  98  96  96  97  95  96  95  96  96  97  ~KS  98  97  96  99  93  97  97  97  96  96  "~KEN  99  98  98  95  96  98  97  98  98  99  ~ARV  98  98  99  97  93  96  96  96  96  96  -5 BIB  91  91  90  91  90  96  95  96  95  96  ~VEN  92  91  91  91  91  93  99  98  99  99  WRC  96  96  96  96  96  90  92  98  98  98  185  99  98  97  98  98  91  91  96  98  99  NI  96  95  95  96  95  90  91  96  96  98  N2  96  95  95  96  95  90  92  94  96  94   N gene  BUC  98  99  100  97  97  100  98  99  100  100  PF  99  99  98  99  95  98  96  97  98  98  KS  99  99  99  98  96  99  97  98  99  99  ~KEN  99  98  98  97  97  100  98  99  100  100  6 ARV  98  99  99  97  94  97  95  96  97  97  BIB  95  94  95  94  94  97  95  96  97  97  ~VEN  99  98  98  98  98  94  98  99  100  100  Z WRC  99  98  98  98  98  94  98  97  98  98  185  99  98  98  98  98  94  98  98  99  99  NI  99  98  98  98  97  95  99  98  98  100  N2  98  97  97  98  97  95  98  97  97  98 the nucleotide sequence level. The results verify that the M and N proteins of EAV are conserved between geographically distinct isolates of virus, and that no major variation is evident in these proteins between respiratory isolates, venereal isolates and the liveattenuated vaccine virus. Table 1 for EA¥ isolate abbreviations.
further upstream in the 5' sequence may contribute to the phenomenon of genetic recombination, but this has yet to be confirmed conclusively by in vitro assays with mixed virus infections.
